A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice - PubMed (original) (raw)
A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice
Y Fukui et al. Diabetes. 2000 May.
Abstract
Thiazolidinediones (TZDs) reduce insulin resistance in type 2 diabetes by increasing peripheral uptake of glucose, and they bind to and activate the transcriptional factor peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Studies have suggested that TZD-induced activation of PPAR-gamma correlates with antidiabetic action, but the mechanism by which the activated PPAR-gamma is involved in reducing insulin resistance is not known. To examine whether activation of PPAR-gamma directly correlates with antidiabetic activities, we compared the effects of 4 TZDs (troglitazone, pioglitazone, BRL-49653, and a new derivative, NC-2100) on the activation of PPAR-gamma in a reporter assay, transcription of the target genes, adipogenesis, plasma glucose and triglyceride levels, and body weight using obese KKAy mice. There were 10- to 30-fold higher concentrations of NC-2100 required for maximal activation of PPAR-gamma in a reporter assay system, and only high concentrations of NC-2100 weakly induced transcription of the PPAR-gamma but not PPAR-alpha target genes in a whole mouse and adipogenesis of cultured 3T3L1 cells, which indicates that NC-2100 is a weak PPAR-gamma activator. However, low concentrations of NC-2100 efficiently lowered plasma glucose levels in KKAy obese mice. These results strongly suggest that TZD-induced activation of PPAR-gamma does not directly correlate with antidiabetic (glucose-lowering) action. Furthermore, NC-2100 caused the smallest body weight increase of the 4 TZDs, which may be partly explained by the finding that NC-2100 efficiently induces uncoupling protein (UCP)-2 mRNA and significantly induces UCP1 mRNA in white adipose tissue (WAT). NC-2100 induced UCP1 efficiently in mesenteric WAT and less efficiently in subcutaneous WAT, although pioglitazone and troglitazone also slightly induced UCP1 only in mesenteric WAT. These characteristics of NC-2100 should be beneficial for humans with limited amounts of brown adipose tissue.
Similar articles
- Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.
Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Moller DE. Kelly LJ, et al. Endocrinology. 1998 Dec;139(12):4920-7. doi: 10.1210/endo.139.12.6384. Endocrinology. 1998. PMID: 9832429 - Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Hanaoka I, Inoue G, Nishimura H, Yoshimasa Y, Yamori Y, Odaka H, Nakao K. Matsuda J, et al. Diabetes. 1998 Nov;47(11):1809-14. doi: 10.2337/diabetes.47.11.1809. Diabetes. 1998. PMID: 9792555 - Novel insulin sensitizers: pharmacogenomic aspects.
Otto C, Lehrke M, Göke B. Otto C, et al. Pharmacogenomics. 2002 Jan;3(1):99-116. doi: 10.1517/14622416.3.1.99. Pharmacogenomics. 2002. PMID: 11966407 Review. - [Mechanisms of action of thiazolidinediones].
Girard J. Girard J. Diabetes Metab. 2001 Apr;27(2 Pt 2):271-8. Diabetes Metab. 2001. PMID: 11452221 Review. French.
Cited by
- Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia.
Qin Y, Bily D, Aguirre M, Zhang K, Xie L. Qin Y, et al. Nutrients. 2023 May 25;15(11):2459. doi: 10.3390/nu15112459. Nutrients. 2023. PMID: 37299422 Free PMC article. Review. - Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies.
Recinella L, De Filippis B, Libero ML, Ammazzalorso A, Chiavaroli A, Orlando G, Ferrante C, Giampietro L, Veschi S, Cama A, Mannino F, Gasparo I, Bitto A, Amoroso R, Brunetti L, Leone S. Recinella L, et al. Pharmaceuticals (Basel). 2023 Feb 24;16(3):346. doi: 10.3390/ph16030346. Pharmaceuticals (Basel). 2023. PMID: 36986448 Free PMC article. - Naringenin, a citrus flavanone, enhances browning and brown adipogenesis: Role of peroxisome proliferator-activated receptor gamma.
Bae J, Yang Y, Xu X, Flaherty J, Overby H, Hildreth K, Chen J, Wang S, Zhao L. Bae J, et al. Front Nutr. 2022 Nov 10;9:1036655. doi: 10.3389/fnut.2022.1036655. eCollection 2022. Front Nutr. 2022. PMID: 36438760 Free PMC article. - Nuclear Receptors in Energy Metabolism.
Walth-Hummel AA, Herzig S, Rohm M. Walth-Hummel AA, et al. Adv Exp Med Biol. 2022;1390:61-82. doi: 10.1007/978-3-031-11836-4_4. Adv Exp Med Biol. 2022. PMID: 36107313 - Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy.
Zhang Q, Ye R, Zhang YY, Fan CC, Wang J, Wang S, Chen S, Liu X. Zhang Q, et al. Front Endocrinol (Lausanne). 2022 May 19;13:847249. doi: 10.3389/fendo.2022.847249. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35663310 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials